drugset / Trial / NCT01113346
A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis
Phase 2/3
Unknown
150 enrolled
Avva Rus, JSC
Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G. · collabSt. Vladimir Moscow Children's Clinical Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II double blind multicenter randomized placebo-controled clinical study aimed to find out whether treatment with Filtrum-STI (orally administered 0,4g tablets) is safe and effective in children with viral gastroenteritis. Filtrum-STI (lignin hydrolytic) is a drug with a high absorbing ability, that binds and eliminates toxins, pathogenic microorganisms and viruses. Filtrum-STI is inoffensive for mucous membranes, enhances colonic propulsion and improves its natural microflora. The drug is not toxic and well combines with other medication
Timeline
- Start
- 2010-06
- Primary completion
- 2010-12
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Filtrum-STI | Unknown | 400 mg | Oral |
| Subject | Filtrum-STI | Unknown | 800 mg | Oral |